Hairy Cell Leukemia-HCL
Hairy cell leukemia (HCL) is a slow-growing cancer of the blood and bone marrow.
It causes abnormal B cells with hair-like projections that crowd out healthy cells.
Modern targeted therapies offer excellent long-term control.
Overview And Clinical Background
HCL is a chronic lymphoproliferative disorder that primarily affects middle-aged adults.
It progresses slowly and responds well to therapy.
Symptoms, Signs And Presentation
Symptoms arise due to bone marrow failure and splenic enlargement.
Infections and fatigue are common.
Diagnosis Methods And Investigations
Imaging And Laboratory Tests
Diagnosis involves blood smear, bone marrow biopsy, and immunophenotyping.
Treatment Options And Surgical Techniques
Therapy focuses on restoring blood cell levels and controlling symptoms.
Most patients achieve long-term remission.
Recovery, Risks And Prognosis
Most patients achieve remission lasting over a decade.
Relapses are managed effectively with re-treatment.
Why Choose Us
CureU Healthcare’s hematology team offers personalized treatment using advanced immunotherapy and precise monitoring for long-term remission.
Conclusion
Hairy cell leukemia, though rare, has an excellent outlook.
With appropriate care, most patients enjoy normal life expectancy.
